Richard Charles Hartley

Title: Richard Charles Hartley: Innovator in Pharmaceutical Compounds

Introduction

Richard Charles Hartley is a notable inventor based in Glasgow, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating various diseases. With a total of 3 patents to his name, Hartley's work focuses on innovative solutions for health-related challenges.

Latest Patents

Hartley's latest patents include groundbreaking inventions such as mitochondria-targeted dicarbonyl sequestering compounds. This invention relates to compounds that can effectively treat diabetes, specifically hyperglycemic diabetes. The compounds are characterized by a specific formula that includes a dicarbonyl sequestering moiety and a mitochondrial targeting moiety. Additionally, he has developed a mass spectrometry probe and a method for labeling biological molecules for mass spectrometry detection. Another significant invention provides compounds that can prevent oxidative damage, UV damage to the skin, and the effects of aging.

Career Highlights

Throughout his career, Richard Charles Hartley has worked with reputable organizations such as Antoxis Limited and the Medical Research Council. His work in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Hartley has collaborated with notable individuals in his field, including Donald Barton McPhail and Stuart Thomas Caldwell. These collaborations have further enriched his research and innovation efforts.

Conclusion

Richard Charles Hartley is a distinguished inventor whose work in pharmaceutical compounds has the potential to impact health care significantly. His innovative patents and collaborations highlight his commitment to advancing medical science.